natgillin/translations-raw huggingface dataset:
I, the undersigned official inspector, declare that I am aware of the relevant provisions of Regulations (EC) No 178/2002, (EC) No 852/2004, (EC) No 853/2004 and (EC) No 854/2004 and hereby certify that the colostrum/colostrum-based products made with colostrum (1) described in Part I were produced in accordance with those provisions, and in particular that:
Podpisani uradni inšpektor izjavljam, da sem seznanjen z ustreznimi določbami uredb (ES) št. 178/2002, (ES) št. 852/2004, (ES) št. 853/2004 in (ES) št. 854/2004, ter potrjujem, da so bili kolostrum/proizvodi na osnovi kolostruma narejeni s kolostrumom (1), opisani v delu I, proizvedeni v skladu z navedenimi določbami in zlasti, da:
they were manufactured from colostrum:
so bili proizvedeni iz kolostruma:
which comes from holdings registered in accordance with Regulation (EC) No 852/2004 and checked in accordance with Annex IV to Regulation (EC) No 854/2004;
ki prihaja z gospodarstev, registriranih v skladu z Uredbo (ES) št. 852/2004 in pregledanih v skladu s Prilogo IV k Uredbi (ES) št. 854/2004;
which was produced, collected, cooled, stored and transported in accordance with the hygiene conditions laid down in Chapter I of Section IX of Annex III to Regulation (EC) No 853/2004;
ki je bil proizveden, zbran, ohlajen, skladiščen in prepeljan v skladu z ustreznimi higienskimi pogoji iz poglavja I oddelka IX Priloge III k Uredbi (ES) št. 853/2004;
which complies with the guarantees on the residues status of colostrum provided by the monitoring plans for the detection of residues or substances submitted in accordance with Directive 96/23/EC, and in particular, Article 29 thereof;
ki izpolnjuje jamstva glede vsebnosti ostankov v kolostrumu, določena v načrtih spremljanja za odkrivanje ostankov ali snovi, predloženih v skladu z Direktivo 96/23/ES, zlasti s členom 29 Direktive;
which, pursuant to testing for residues of antibacterial drugs carried out by the food business operator in accordance with the requirements of point 4 in Part III of Chapter I of Section IX of Annex III to Regulation (EC) No 853/2004, complies with the maximum residue limits for residues of antibacterial veterinary medicinal products laid down in the Annex to Regulation (EU) No 37/2010;
ki po testiranju na ostanke protimikrobnih zdravil, ki ga izvaja nosilec živilske dejavnosti v skladu z zahtevami točke 4 dela III poglavja I oddelka IX Priloge III k Uredbi (ES) št. 853/2004, izpolnjuje mejne vrednosti ostankov protimikrobnih zdravil za uporabo v veterinarski medicini iz Priloge k Uredbi (EU) št. 37/2010;
which has been produced under conditions guaranteeing compliance with the maximum residue levels for pesticides laid down in Regulation (EC) No 396/2005, and maximum levels for contaminants laid down in Regulation (EC) No 1881/2006;
ki je bil proizveden pod pogoji, ki zagotavljajo upoštevanje mejnih vrednosti ostankov pesticidov iz Uredbe (ES) št. 396/2005 in mejnih vrednosti onesnaževal iz Uredbe (ES) št. 1881/2006;
they come from an establishment implementing a programme based on the HACCP principles in accordance with Regulation (EC) No 852/2004;
prihajajo iz obrata, ki izvaja program na podlagi načel HACCP v skladu z Uredbo (ES) št. 852/2004;
they have been processed, stored, wrapped, packaged and labeled in accordance with Chapters III and IV of Section IX of Annex III to Regulation (EC) No 853/2004;
so bili predelani, skladiščeni, zaviti, pakirani in označeni v skladu s poglavjema III in IV oddelka IX Priloge III k Uredbi (ES) št. 853/2004;
they meet the relevant requirements laid down in Chapter II, Section IX of Annex III to Regulation (EC) N0 853/2004 and the relevant microbiological criteria laid down in Regulation (EC) No 2073/2005 on microbiological criteria for foodstuffs, and
izpolnjujejo ustrezne zahteve iz poglavja II oddelka IX Priloge III k Uredbi (ES) št. 853/2004 in ustrezna mikrobiološka merila iz Uredbe (ES) št. 2073/2005 o mikrobioloških merilih za živila, ter
the guarantees covering live animals and products thereof provided by the residue plans submitted in accordance with Directive 96/23/EC, and in particular Article 29 thereof are fulfilled.
so izpolnjena jamstva, ki veljajo za žive živali in njihove proizvode ter so določena v načrtih o ostankih, predloženih v skladu z Direktivo 96/23/ES, zlasti s členom 29 Direktive.
This certificate is intended for colostrum or colostrum–based products from third countries or parts thereof authorised in column A of Annex I to Regulation (EU) No 605/2010.
To je spričevalo za kolostrum/proizvode na osnovi kolostruma iz tretjih držav ali njihovih delov, ki so odobreni v stolpcu A Priloge I k Uredbi (EU) št. 605/2010.
Box reference I.7: Provide name and ISO code of the country or part thereof as appearing in Annex I to Commission Regulation (EU) No 605/2010 of 2 July 2010 laying down animal and public health and veterinary certification conditions for the introduction into the European Union of raw milk and dairy products intended for human consumption (OJ L 175, 10.7.2010, p. 1).
Rubrika I.7: navesti ime in oznako ISO države ali njenega dela, kot je navedeno v Prilogi I k Uredbi Komisije (EU) št. 605/2010 z dne 2. julija 2010 o pogojih zdravstvenega varstva živali, javnozdravstvenih pogojih in veterinarskih spričevalih za vnos surovega mleka in mlečnih proizvodov, namenjenih za prehrano ljudi, v Evropsko unijo (UL L 175, 10.7.2010, str. 1).
Box reference I.19: Use the appropriate Harmonised System (HS) code under the following headings: 04.01; 04.02; 04.03; 04.04; 04.05; 04.06; 04.10; 15.17; 17.02; 19.01; 21.05; 21.06; 22.02; 28.35; 30.01; 35.01; 35.02 or 35.04.
Rubrika I.19: uporabiti ustrezno oznako HS pod naslednjimi številkami: 04.01; 04.02; 04.03; 04.04; 04.05; 04.06; 04.10; 15.17; 17.02; 19.01; 21.05; 21.06; 22.02; 28.35; 30.01; 35.01; 35.02 ali 35.04.
Part 3, is replaced by the following:
del 3 se nadomesti z naslednjim:
Model Milk/Colostrum-T/S
Vzorec za mleko/kolostrum – T/S
Animal Health Certificate for raw milk, dairy products, colostrum and colostrum-based products for human consumption intended for transit through or storage in the European Union
Zdravstveno spričevalo za surovo mleko, mlečne proizvode, kolostrum in proizvode na osnovi kolostruma, namenjene za prehrano ljudi in za tranzit ali skladiščenje v Evropski uniji
Raw milk, dairy products, colostrum and colostrum-based products for human consumption for transit or storage
Surovo mleko, mlečni proizvodi, kolostrum in proizvodi na osnovi kolostruma, namenjeni za prehrano ljudi in tranzit ali skladiščenje
I, the undersigned official veterinarian, hereby certify that the [raw milk] / [dairy products] / [colostrum] / [colostrum-based products] (1) (2) for [transit] / [storage] (2) in the European Union described in Part I:
[surovo mleko]/[mlečni proizvodi]/[kolostrum]/[proizvodi na osnovi kolostruma] (1) (2) namenjen(-o/-i) za [tranzit]/[skladiščenje] (2) v Evropski uniji, kot so opisani v delu I:
come from a country or part thereof authorised for imports to the European Union of raw milk, dairy products, colostrum or colostrum-based products as laid down in Annex I to Regulation (EU) No 605/2010;
prihaja(-jo) iz države ali njenega dela, ki ima dovoljenje za uvoz surovega mleka, mlečnih proizvodov, kolostruma ali proizvodov na osnovi kolostruma v Evropsko unijo, kot je določeno v Prilogi I k Uredbi (EU) št. 605/2010;
comply with the relevant animal health conditions for the products concerned as laid down in the animal health attestation in Part II.1 of the model health certificates [Milk-RM] / [Milk-RMP] / [Milk-HTB] / [Milk-HTC]/[Colostrum-C/CBP](2) in Part 2 of Annex II to Regulation (EU) No 605/2010;
izpolnjuje(-jo) ustrezne pogoje zdravstvenega varstva živali za zadevne proizvode, kot so določeni v potrdilu o zdravstvenem stanju živali v delu II.1 vzorca zdravstvenega spričevala [mleko – RM]/[mleko – RMP]/[mleko – HTB]/[mleko – HTC]/[kolostrum – C/CBP] (2) iz dela 2 Priloge II k Uredbi (EU) št. 605/2010;
was/were produced on … (3) or between … (3) and … (3).
je bilo pridobljen(-o)/so bili pridobljeni … (3) ali med … (3) in … (3).
Box reference I.19: Use the appropriate Harmonised System (HS) code under the following headings: 04.01; 04.02; 04.03; 04.04; 04.05; 04.06; 15.17; 17.02; 19.01; 21.05; 21.06.; 22.02; 28.35; 30.01; 35.01; 35.02; 35.04 or 04.10.
Rubrika I.19: uporabiti ustrezno oznako HS pod naslednjimi številkami: 04.01; 04.02; 04.03; 04.04; 04.05; 04.06; 15.17; 17.02; 19.01; 21.05; 21.06.; 22.02; 28.35; 30.01; 35.01; 35.02; 35.04 ali 04.10.
Raw milk, dairy products, colostrum and colostrum –based products means raw milk, dairy products, colostrum and colostrum-based products for human consumption in transit or storage in accordance with Article 12(4) or Article 13 of Council Directive 97/78/EC of 18 December 1997 laying down the principles governing the organisation of veterinary checks on products entering the Community from third countries (OJ L 24, 30.1.1998, p. 9).
Surovo mleko, mlečni proizvodi, kolostrum in proizvodi na osnovi kolostruma pomenijo surovo mleko, mlečne proizvode, kolostrum in proizvode na osnovi kolostruma za prehrano ljudi v tranzitu ali skladiščeni v skladu s členom 12(4) ali členom 13 Direktive Sveta 97/78/ES z dne 18. decembra 1997 o določitvi načel, ki urejajo organizacijo veterinarskih pregledov proizvodov, ki vstopajo v Skupnost iz tretjih držav (UL L 24, 30.1.1998, str. 9).
Date or dates of production.
Datum ali datumi proizvodnje.
Imports of raw milk, dairy products, colostrum and colostrum-based products shall not be allowed when obtained either prior to the date of authorisation for exportation to the European Union of the third country or part thereof mentioned under I.7 and I.8, or during a period where restrictive measures have been adopted by the European Union against imports of raw milk, dairy products, colostrum and colostrum-based products from this third country or part thereof.
Uvoz surovega mleka, mlečnih proizvodov, kolostruma in proizvodov na osnovi kolostruma se ne dovoli, če so bili proizvedeni pred datumom odobritve izvoza v Evropsko unijo iz tretje države ali njenega dela iz rubrik I.7 in I.8 ali v času, ko je Evropska unija sprejela omejevalne ukrepe za uvoz surovega mleka, mlečnih proizvodov, kolostruma in proizvodov na osnovi kolostruma iz te tretje države ali njenega dela.
OJ L 13, 16.1.1997, p. 28.’
UL L 13, 16.1.1997, str. 28.“;
Commission Implementing Regulation (EU) No 210/2014
Izvedbena uredba Komisije (EU) št. 210/2014
Commission Implementing Regulation (EU) No 211/2014
Izvedbena uredba Komisije (EU) št. 211/2014
correcting the Slovak language version of Commission Regulation (EC) No 340/2008 on the fees and charges payable to the European Chemicals Agency pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
o popravku slovaške jezikovne različice Uredbe Komisije (ES) št. 340/2008 o pristojbinah in taksah, plačljivih Evropski agenciji za kemikalije na podlagi Uredbe (ES) št. 1907/2006 Evropskega parlamenta in Sveta o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH)
In the Slovak language version, an error occurring three times in Table 4 of Annex III to Commission Regulation (EC) No 340/2008 [2], as amended by Implementing Regulation (EU) No 254/2013 [3], should be corrected.
V slovaški jezikovni različici bi bilo treba popraviti napako, ki se trikrat pojavi v Preglednici 4 Priloge III k Uredbi Komisije (ES) št. 340/2008 [2], kakor je bila spremenjena z Izvedbeno uredbo (EU) št. 254/2013 [3].
Regulation (EC) No 340/2008 should therefore be corrected accordingly.
Uredbo (ES) št. 340/2008 bi bilo zato treba ustrezno popraviti.
Concerns only the Slovak language version.
Zadeva le slovaško jezikovno različico.
Commission Regulation (EC) No 340/2008 of 16 April 2008 on the fees and charges payable to the European Chemicals Agency pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (OJ L 107, 17.4.2008, p. 6).
Uredba Komisije (ES) št. 340/2008 z dne 16. aprila 2008 o pristojbinah in taksah, plačljivih Evropski agenciji za kemikalije na podlagi Uredbe (ES) št. 1907/2006 Evropskega parlamenta in Sveta o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH) (UL L 107, 17.4.2008, str. 6).
Commission Implementing Regulation (EU) No 254/2013 of 20 March 2013 amending Regulation (EC) No 340/2008 on the fees and charges payable to the European Chemicals Agency pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (OJ L 79, 21.3.2013, p. 7).
Izvedbena uredba Komisije (EU) št. 254/2013 z dne 20. marca 2013 o spremembi Uredbe Komisije (ES) št. 340/2008 o pristojbinah in taksah, plačljivih Evropski agenciji za kemikalije na podlagi Uredbe (ES) št. 1907/2006 Evropskega parlamenta in Sveta o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH) (UL L 79, 21.3.2013, str. 7).
Commission Regulation (EU) No 212/2014
Uredba Komisije (EU) št. 212/2014
of 6 March 2014
z dne 6. marca 2014
amending Regulation (EC) No 1881/2006 as regards maximum levels of the contaminant citrinin in food supplements based on rice fermented with red yeast Monascus purpureus
o spremembi Uredbe (ES) št. 1881/2006 glede mejnih vrednosti onesnaževala citrinin v prehranskih dopolnilih na osnovi riža, fermentiranega z rdečimi kvasovkami Monascus purpureus
Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in foodstuffs [2] sets maximum levels for mycotoxins in food.
V Uredbi Komisije (ES) št. 1881/2006 z dne 19. decembra 2006 o določitvi mejnih vrednosti nekaterih onesnaževal v živilih [2] so določene mejne vrednosti za mikotoksine v živilih.
The Scientific Panel on Contaminants in the Food Chain (The Panel on Contaminants) of the European Food Safety Authority (EFSA) has, on a request from the Commission, adopted on 2 March 2012 an opinion on the risks for public and animal health related to the presence of citrinin in food and feed [3].
Znanstveni odbor za onesnaževala v prehranski verigi (Odbor za onesnaževala) Evropske agencije za varnost hrane (EFSA) je 2. marca 2012 na zahtevo Komisije sprejel mnenje o tveganjih za javno zdravje in zdravje živali, povezanih s prisotnostjo citrinina v živilih in krmi [3].
The Panel on Contaminants decided to characterise the risk of citrinin on the available data on nephrotoxicity and determined a level of no concern for nephrotoxicity.
Odbor za onesnaževala je sklenil opredeliti tveganje, ki ga pomeni citrinin, na podlagi razpoložljivih podatkov o nefrotoksičnosti in določil raven, ki ni zaskrbljujoča za nefrotoksičnost.
Applying an uncertainty factor of 100 to the No Observed Adverse Effect Level (NOAEL) of 20 μg/kg bodyweight (b.w.) per day results in a level of no concern for nephrotoxicity in humans of 0,2 μg/kg b.w. per day.
Če se za raven brez opaženega škodljivega učinka (NOAEL) v višini 20 μg/kg telesne teže na dan uporabi faktor negotovosti v višini 100, je raven, ki ni zaskrbljujoča za nefrotoksičnost pri ljudeh, 0,2 μg/kg telesne teže na dan.
The Panel on Contaminants concluded that based on the available data, a concern for genotoxicity and carcinogenicity could not be excluded as regards citrinin at the level of no concern for nephrotoxicity.
Odbor za onesnaževala je sklenil, da na podlagi razpoložljivih podatkov ni mogoče izključiti zaskrbljenosti za genotoksičnost in rakotvornost citrinina pri ravni, ki ni zaskrbljujoča za nefrotoksičnost.
The Scientific Panel on Dietetic Products, Nutrition and Allergies (The NDA Panel) of EFSA has, on request of the Competent Authority of the Netherlands following an application by Sylvan Bio Europe BV, adopted on 24 January 2013 an opinion on the substantiation of a health claim related to monacolin K in SYLVAN BIO red yeast rice and maintenance of normal blood LDL-cholesterol concentration pursuant to Article 13(5) of Regulation (EC) No 1924/2006 [4].
Znanstveni odbor agencije EFSA za dietetične izdelke, prehrano in alergije (Odbor NDA) je na zahtevo pristojnega nizozemskega organa na podlagi vloge družbe Sylvan Bio Europe BV 24. januarja 2013 sprejel mnenje o utemeljitvi zdravstvene trditve v zvezi z učinkom monakolina K iz rdečega kvasnega riža SYLVAN BIO na vzdrževanje normalne koncentracije LDL-holesterola v krvi v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 [4].
The NDA Panel concluded that a cause and effect relationship has been established between the consumption of monacolin K in red yeast rice preparations and maintenance of normal blood LDL-cholesterol concentrations.
Odbor NDA je sklenil, da je bila vzpostavljena vzročno-posledična povezava med uživanjem monakolina K iz pripravkov rdečega kvasnega riža in vzdrževanjem normalne koncentracije LDL-holesterola v krvi.
The NDA Panel considers that the following wording reflects the scientific evidence: ‘Monacolin K from red yeast rice contributes to the maintenance of normal blood cholesterol concentrations’ and in order to obtain the claimed effect, 10 mg of monacolin K from fermented red yeast rice preparations should be consumed daily.
Odbor NDA meni, da naslednje besedilo odraža znanstvene dokaze: „Monakolin K iz rdečega kvasnega riža prispeva k vzdrževanju normalne koncentracije holesterola v krvi“, za dosego želenega učinka pa je treba dnevno zaužiti 10 mg monakolina K iz pripravkov fermentiranega rdečega kvasnega riža.
The target population is adults in the general population.
Ciljna populacija so odrasli v širši populaciji.
The health claim can be applied to all red yeast rice preparations on the market.
Zdravstvena trditev se lahko navede na vseh pripravkih rdečega kvasnega riža na trgu.
Monacolin K is produced by Monascus purpureus of which some strains produce also citrinin.
Monakolin K proizvajajo kvasovke Monascus purpureus, od katerih nekateri sevi prav tako proizvajajo citrinin.
Data available on the presence of citrinin in certain red yeast rice preparations revealed high levels of citrinin in those preparations.
Razpoložljivi podatki o prisotnosti citrinina v nekaterih pripravkih rdečega kvasnega riža so pokazali visoko vsebnost citrinina v navedenih pripravkih.
The consumption of such red yeast rice preparations at the quantity necessary to obtain the claimed effect would result in an exposure significantly above the level of no concern for nephrotoxicity of citrinin.
Uživanje takih pripravkov rdečega kvasnega riža v količini, ki je potrebna za dosego navedenega učinka, bi pomenila stopnjo izpostavljenosti, ki bi bila bistveno nad ravnjo, ki ni zaskrbljujoča za nefrotoksičnost citrinina.
Therefore it is appropriate to establish a maximum level for citrinin in red yeast rice preparations.
Zato je primerno določiti mejno vrednost citrinina v pripravkih rdečega kvasnega riža.
To obtain the necessary intake of monacolin K, 4-6 capsules of 600 mg of red yeast rice need to be consumed.
Za potreben vnos monakolina K je treba zaužiti 4–6 600-miligramskih kapsul rdečega kvasnega riža.
A maximum level of 2 mg/kg for citrinin in red yeast rice preparation has been established in order to ensure that the possible exposure to citrinin from these red yeast rice preparations remains significantly below the level of nephrotoxicity of 0,2 μg/kg bw foe an adult.
Mejna vrednost citrinina v rdečem kvasnem rižu v višini 2 mg/kg je bila določena za zagotovitev, da morebitna izpostavljenost citrininu iz teh pripravkov rdečega kvasnega riža ostane bistveno pod ravnjo, ki je nefrotoksična, tj. 0,2 μg/kg telesne teže za odraslega.
Given the gaps in knowledge as regards the presence of citrinin in other foodstuffs and the remaining uncertainties as regards the carcinogenicity and genotoxicity of citrinin, it is appropriate to review the maximum level within two years’ time once more information has been gathered as regards the toxicity of citrinin and the exposure from other foodstuffs.
Zaradi pomanjkljivih informacij o prisotnosti citrinina v drugih živilih in ostalih negotovostih glede rakotvornosti in genotoksičnosti citrinina je primerno pregledati mejno vrednost v dveh letih, ko bo zbranih več informacij glede toksičnosti citrinina in izpostavljenosti prek drugih živil.
The addition of substances to or the use of substances in foodstuffs is governed by specific Union and national legislation, as is the classification of products as foodstuffs or medicinal products.
Dodajanje snovi živilom oziroma njihovo uporabo v živilih ter razvrstitev proizvodov med živila ali zdravila urejata posebna zakonodaja Unije in nacionalna zakonodaja.
The setting of a maximum level in such a substance or product does not constitute an authorisation to the marketing of the substance for which a maximum level is established, a decision on whether the substance can be used in foodstuffs, or a classification of a certain product as a foodstuff.
Določitev mejne vrednosti za tako snov ali proizvod ne pomeni izdaje dovoljenja za promet s snovjo, za katero je bila določena mejna vrednost, odločitve, ali se snov lahko uporablja v živilih, ali razvrstitve določenega proizvoda med živila.
In section 2 of the Annex to Regulation (EC) No 1881/2006, the following entries 2.8 and 2.8.1 are added:
V oddelku 2 Priloge k Uredbi (ES) št. 1881/2006 se dodata naslednja vnosa 2.8 in 2.8.1:
Food supplements based on rice fermented with red yeast Monascus purpureus
prehranska dopolnila na osnovi riža, fermentiranega z rdečimi kvasovkami Monascus purpureus
Done at Brussels, 6 March 2014.
V Bruslju, 6. marca 2014
EFSA Panel on Contaminants in the Food Chain (CONTAM); Scientific Opinion on the risks for public and animal health related to the presence of citrinin in food and feed.
Znanstveni odbor agencije EFSA za onesnaževala v prehranski verigi (CONTAM); Znanstveno mnenje o tveganjih za javno zdravje in zdravje živali, povezanih s prisotnostjo citrinina v živilih in krmi (Scientific Opinion on the risks for public and animal health related to the presence of citrinin in food and feed).
[82 pp.] doi:10.2903/j.efsa.2012.2605.
[82 str.] doi:10.2903/j.efsa.2012.2605.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to monacolin K in SYLVAN BIO red yeast rice and maintenance of normal blood LDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
Odbor agencije EFSA za dietetične izdelke, prehrano in alergije (Odbor NDA); Znanstveno mnenje o utemeljitvi zdravstvene trditve v zvezi z učinkom monakolina K iz rdečega kvasnega riža SYLVAN BIO na vzdrževanje normalne koncentracije LDL-holesterola v krvi (Scientific Opinion on the substantiation of a health claim related to monacolin K in SYLVAN BIO red yeast rice and maintenance of normal blood LDL-cholesterol concentrations) v skladu s členom 13(5) Uredbe (ES) št. 1924/2006.
[13 pp.]. doi:10.2903/j.efsa.2013.3084.
[13 str.]. doi: 10.2903/j.efsa.2013.3084.
The maximum level is to be reviewed before 1 January 2016 in the light of information on exposure to citrinin from other foodstuffs and updated information on the toxicity of citrinin in particular as regards carcinogenicity and genotoxicity.’
Mejna vrednost se pregleda pred 1. januarjem 2016 na podlagi podatkov o izpostavljenosti citrininu prek drugih živil in posodobljenih informacij o toksičnosti citrinina, zlasti glede rakotvornosti in genotoksičnosti.“
Commission Implementing Regulation (EU) No 213/2014
Izvedbena uredba Komisije (EU) št. 213/2014
Commission Regulation (EU) No 214/2014
Uredba Komisije (EU) št. 214/2014
amending Annexes II, IV, XI, XII and XVIII to Directive 2007/46/EC of the European Parliament and of the Council establishing a framework for the approval of motor vehicles and their trailers, and of systems, components and separate technical units intended for such vehicles
o spremembi prilog II, IV, XI, XII in XVIII k Direktivi 2007/46/ES Evropskega Parlamenta in Sveta o vzpostavitvi okvira za odobritev motornih in priklopnih vozil ter sistemov, sestavnih delov in samostojnih tehničnih enot, namenjenih za taka vozila